Figure 2.

Comparison of the ristocetin-induced platelet aggregation between the anti-platelet and control groups of type 2 DM patients. PRP from patients of type 2 DM in the anti-platelet group (n=15) and PRP from patients of the control group (n=31) were stimulated by 1.5 mg/ml of ristocetin or vehicle in an aggregometer at 37°C for 4 min with a stirring speed of 800 rpm. The value of AUC of transmittance in the two groups are presented as mean ± standard deviation. *P<0.05, compared to the value without ristocetin. N.S. designates statistically not significant between the pair. PRP, platelet-rich plasma; DM, diabetes mellitus; AUC, area-under curve.